Xingyue Lu

Xingyue Lu

Auto-generated profile, based on publicly available information

Xingyue Lu

School of Pharmacy, Bengbu Medical College, Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, Anhui, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
XLxiaoting liang
xiaoting liang
YDYue Ding
Yue Ding
FLFang Lin
Fang Lin
YZYuelin Zhang
Yuelin Zhang
XZXiaohui Zhou
Xiaohui Zhou
ZLZhongmin Liu
Zhongmin Liu
The age‐related functional exhaustion limits potential efficacy of mesenchymal stem cells (MSC) in treating cardiovascular disease. Therefore, rejuvenation of aged MSC in the elderly population is of great interest. We have previously reported that Erb‐B2 receptor tyrosine kinase 4 ( ERBB4 ) plays a critical role in regulating MSC survival under hypoxia. The aim of this study was to investigate whether ERBB4 rejuvenates aged MSC and how ERBB4 enhances therapeutic efficacy of aged MSC in treating myocardial infarction (MI). Compared with vector aged MSC (aged‐MSC), ERBB4‐engineered aged MSC (ER4‐aged‐MSC) conferred resistance to oxidative stress‐induced cell death and ameliorated the senescent phenotype in vitro . Four weeks after MI, the ER4‐aged‐MSC group exhibited enhanced blood vessel density, reduced cardiac remodeling and apoptosis with improved heart function compared with the aged‐MSC group. Overexpression of ERBB4 caused an increase in phosphorylated v‐akt murine thymoma viral oncogene homolog 1 (AKT), and phosphorylated ERK expression under hypoxia. ER4‐aged‐MSC secreted higher levels of angiopoietin, epithelial neutrophil activating peptide 78, VEGF, and fibroblast growth factor 2, and enhanced tube formation in HUVEC. The impact of ERBB4 on protein expression, proangiogenesis, cell behavior, and cytokine secretion was abolished by inhibiting PI3K/AKT and MAPK/ERK signaling pathway.—Liang, X., Ding, Y., Lin, F., Zhang, Y., Zhou, X., Meng, Q., Lu, X., Jiang, G., Zhu, H., Chen, Y., Lian, Q., Fan, H., Liu, Z. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways. FASEB J. 33, 4559–4570 (2019). www.fasebj.org

1 June 2020 in Gene
Verified
Journal Article
Closed access
PZPei Zhang
Pei Zhang
SZSurong Zhao
Surong Zhao
XLXingyue Lu
Xingyue Lu
ZSZongfen Shi
Zongfen Shi
HLHao Liu
Hao Liu
BZBing Zhu
Bing Zhu

1 August 2019 in Gene
Verified
Journal Article
Closed access
PZPei Zhang
Pei Zhang
XLXingyue Lu
Xingyue Lu
ZSZongfen Shi
Zongfen Shi
XLXian Li
Xian Li
YZYuelin Zhang
Yuelin Zhang
HLHao Liu
Hao Liu

1 May 2019 in Gene
Verified
Journal Article
Open access
PZPei Zhang
Pei Zhang
XLXingyue Lu
Xingyue Lu
ZSZongfen Shi
Zongfen Shi
XLXian Li
Xian Li
YZYuelin Zhang
Yuelin Zhang
HLHao Liu
Hao Liu